TASIGNA 200 MG 112 CAP

Tasigna (nilotinib) is a medication primarily used in the treatment of chronic myeloid leukemia (CML), a type of cancer that affects the blood and bone marrow. The formulation you’ve mentioned, Tasigna 200 mg capsules, contains nilotinib as the active ingredient. Each capsule typically contains 200 mg of nilotinib along with other inactive ingredients. Nilotinib is classified as a tyrosine kinase inhibitor. It works by inhibiting the activity of certain proteins (tyrosine kinases) that are involved in the growth and proliferation of cancer cells, particularly those associated with CML. By blocking these proteins, nilotinib helps to slow down or stop the growth of cancer cells, thereby aiding in the treatment of CML. It’s essential to take Tasigna exactly as prescribed by your doctor. The dosage and duration of treatment may vary depending on factors such as the type and stage of cancer, your overall health, and other medications you may be taking. Always follow your doctor’s instructions carefully and report any side effects or concerns promptly.